NEW YORK (GenomeWeb) – Researchers at the University of Washington have applied parallel-reaction monitoring (PRM) mass spec to the development of targeted phosphoproteomics assays.

The method, which was detailed in a paper published this week in Nature Methods, leverages PRM's reproducibility and simplicity to generate what the authors, led by UW researcher Judit Villén, described as rapid "plug and play" targeted phosphoprotein assays.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

CNN reports that researchers have tied a new variant to opioid addiction risk.

Organoids derived from patients' tumors may help determine what chemotherapy treatment patients would benefit from, according to New Scientist.

An initiative from GenomeAsia 100K hopes to increase the number of South Asians in genetic research, according to NBC News.

In Science this week: genomic analysis of ancient and modern horses indicates population turnover, and more.